Weiss Lawrence T 4
4 · ANGIODYNAMICS INC · Filed Dec 4, 2024
Insider Transaction Report
Form 4
Weiss Lawrence T
SVP, Chief Legal Officer
Transactions
- Award
Common Stock
2024-12-02+52,697→ 52,697 total - Award
Non-Qualified Stock Option (right to buy)
2024-12-02+103,650→ 103,650 totalExercise: $7.14From: 2025-12-02Exp: 2034-12-02→ Common Stock (103,650 underlying)
Footnotes (2)
- [F1]The acquisition of 52,697 shares of common stock ("Common Stock") of AngioDynamics, Inc.("AngioDynamics") represents 52,697 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on December 2, 2025, such that 25% of the restricted stock units will vest on each of December 2, 2025, 2026, 2027 and 2028.
- [F2]These stock options vest in four equal annual installments beginning on December 2, 2025, such that 25% of the options will vest on each of December 2, 2025, 2026, 2027 and 2028.